Anti-B7-H1/PD-L1/CD274 Antibody (Avelumab)
Catalog No.
F1133
Anti-B7-H1/PD-L1/CD274 Antibody (Avelumab)
Featured Products
Avelumab (anti-PD-L1) is a human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
150 kDa
Dry ice
1537032-82-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Bavencio, MSB-0010718C, PF-06834635
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NZQ7
Human, Mouse, Rat, Cynomolgus, Rabbit, Dog
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human B7-H1 / PD-L1 / CD274 CHO-K Cell Line were stained with Anti-B7-H1/PD-L1/CD274 Antibody (Avelumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 2.02 nM.
B7-H1 / PD-L1 / CD274
Please avoid freeze-thaw cycles.